Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × ferric pyrophosphate × Clear all

NCT01097057 2018-01-23

Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

Phase 2 Completed

20 enrolled 9 charts

Lymphoma, Non-Hodgkin